Term
Cardiac functions is dependent upon adequate amounts of |
|
Definition
ATP Ca With a coordinated electrical stimulus |
|
|
Term
Adequate amounts of ATP are needed to |
|
Definition
Maintain electrochemical gradients Initiate action potential power muscle contraction |
|
|
Term
Adequate amounts of Ca(calcium) are needed to |
|
Definition
^strength of contraction Enhance automaticity Vasoconstricts coronary arteries and peripheral arterioles Glue that links electrical and mechanical events |
|
|
Term
2 types of myocardial tissue |
|
Definition
|
|
Term
Two types of action potentials found in myocardial tissue |
|
Definition
Fast potentials Slow potentials |
|
|
Term
Fast potentials are found in what tissue |
|
Definition
|
|
Term
Contractile tissue is dependent on what ions |
|
Definition
|
|
Term
Slow potentials are found in what tissues |
|
Definition
|
|
Term
SA and AV node tissues depend on what |
|
Definition
|
|
Term
Concerning Dysrhythmia generation: Abnormal Genesis deals with what |
|
Definition
Imbalance of the ANS stimuli Pathologic depolarization |
|
|
Term
Concerning Dysrhythmia generation: What are/is Pathologic depolarization |
|
Definition
Ectopic foci PVC's, PJC's, PAC's |
|
|
Term
All antidysrhythmics have arrhythmogenic properties what does this mean |
|
Definition
They can cause dysrhythmias too |
|
|
Term
What are the AHA recommendation classifications for Cardiacvascular Care |
|
Definition
Class I, class IIa, Class IIb, class III, and indeterminate |
|
|
Term
What are the AHA recommendation classifications for Cardiovascular Care |
|
Definition
Class I, class IIa, Class IIb, class III, and indeterminate |
|
|
Term
What do AHA Cardiovascular classifications mean |
|
Definition
based on supporting evidence: I- clear benefit, should perform IIa- probably helpful, reasonable to perform IIb- risk=to benefit, may be considered III- not helpful, probably harmful indeterminant |
|
|
Term
Vaughn-Williams Classification of Cardiovascular Drugs |
|
Definition
Based on mechanism not evidence Class I, Ia, Ib, Ic, II, III, IV, and MISC. |
|
|
Term
VW(Vaughn Williams) Class I drugs are |
|
Definition
|
|
Term
What do Class Ia,Ib,Ic NA channel blockers do what |
|
Definition
v NA movement v conduction and repolarization rate v excitability Indications: ventricular dysrhythmias |
|
|
Term
|
Definition
slow conduction through ventricles Decrease repolarization rate |
|
|
Term
How do Class IA agents v repolarization rate |
|
Definition
Widen QRS and QT intervals May propmote Torsades des pointes |
|
|
Term
What are some Class Ia agents |
|
Definition
PDQ: procainamide disopyramide qunidine |
|
|
Term
|
Definition
Slow conduction through ventricles ^ V-fib threshold Reduce automaticity May be used for seizures and ICP |
|
|
Term
IB agents reduce automaticity how |
|
Definition
Effective for ectopic foci |
|
|
Term
What are some Class Ib drugs |
|
Definition
LTMD: Lidocaine Tocainide mexaletine phenytoin |
|
|
Term
|
Definition
Slow conduction through ventricles,atria,and conduction system v repolarization v contractility Rare last chance drug |
|
|
Term
What are some Class Ic drugs |
|
Definition
|
|
Term
|
Definition
Potassium Channel Blockers |
|
|
Term
What do Potassium channel blockers do |
|
Definition
v K+ efflux during repolarization Prolongs repolarization which extends effective refractory period Prototype was bretyllium |
|
|
Term
What is the prototype for Potassium channel blockers |
|
Definition
|
|
Term
What are the Contra-indications for Class Ia,Ib,Ic and Class III channel blockers |
|
Definition
2nd and 3rd degree Heart Blocks |
|
|
Term
procainamide is what class of drug |
|
Definition
Class IA- Sodium channel Blocker Antidysrhythmic |
|
|
Term
|
Definition
|
|
Term
|
Definition
Slows conduction of heart Suppress ventricular ectopy by reducing automaticity and ^the refractory period ^ QRS and QT width |
|
|
Term
procainamide (Pronestyl) indications |
|
Definition
All dysrhythmias: SVT, PSVT, A-fib, A-flutter, V-tach, V-fib |
|
|
Term
|
Definition
|
|
Term
lidocaine is what class of drug |
|
Definition
Class IB- Sodium channel blocker Antidysrhythmic |
|
|
Term
|
Definition
Suppress ventricular ectopy dysrhythmias ^ V-fib threshold v automaticity |
|
|
Term
|
Definition
Ventricular dysrhythmias including V-tach V-fib PVC's |
|
|
Term
phenytoin is what class of drug |
|
Definition
Class IB Sodium channel blocker Antiarrhythmic |
|
|
Term
|
Definition
|
|
Term
phenytoin(Dilantin-tm) MOA |
|
Definition
^ Ventricular threshold Prolongs refractory period |
|
|
Term
|
Definition
Arrhythmias caused by digitalis toxicity |
|
|
Term
What class of Antidysrhythmics do we not care about |
|
Definition
Class IC Sodium channel blockers |
|
|
Term
What are class III Antidysrhythmics |
|
Definition
Potassium channel blockers (K+) |
|
|
Term
amiodarone is what class of drug |
|
Definition
Class III Potassium channel blocker Antidysrhythmic |
|
|
Term
|
Definition
|
|
Term
amiodarone (Cordarone-tm) MOA |
|
Definition
Prolongs duration of action potential and refractory period without significantly effecting resting potential; relaxes smooth muscles causing vasodilation especially in coronary arteries. Anti-anginal and sympatholytic properties |
|
|
Term
|
Definition
All tachydisrhythmias Pulseless V-tach / V-fib, SVT, atrial fibrillation, atrial flutter, junctional tachycardia and atrial tachycardias,ventricular tachycardia & wide complex tachycardia of unknown origin; treatment of non-exertional angina |
|
|
Term
bretylium is what class of drug |
|
Definition
Class III Potassium channel blocker Antidysrhythmic |
|
|
Term
|
Definition
|
|
Term
|
Definition
Suppresses re-entry of dysrhythmias by prolonging the depolarization period and the refractory period |
|
|
Term
|
Definition
Refractory V-fib and V- tach |
|
|
Term
Does bretylium have any Contra indications |
|
Definition
None in life threatening situations |
|
|